Poorly Differentiated Hepatocellular Carcinoma Cells Avoid Apoptosis by Interacting with T Cells via CD40–CD40 Ligand Linkage
- 26 March 2024
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 194 (7) , 1230-1247
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development (AMED-CREST- JP23gm1010009, J192640002, AMED-J202620103)
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science (22K08083)
This publication has 44 references indexed in Scilit:
- Soluble Immune Checkpoint Protein CD27 Is a Novel Prognostic Biomarker of Hepatocellular Carcinoma Development in Hepatitis C Virus–Sustained Virological Response PatientsThe American Journal of Pathology, 2022
- Hexa Histidine–Tagged Recombinant Human Cytoglobin Deactivates Hepatic Stellate Cells and Inhibits Liver Fibrosis by Scavenging Reactive Oxygen SpeciesHepatology, 2021
- Update on Hepatocellular Carcinoma: a Brief Review from Pathologist StandpointJournal of Gastrointestinal Cancer, 2020
- Niclosamide: Beyond an antihelminthic drugCellular Signalling, 2018
- Expression of CD40 and growth-inhibitory activity of CD40 ligand in colon cancer ex vivoCellular Immunology, 2008
- CD40‐mediated death and cytokine secretion in colorectal cancer: A potential target for inflammatory tumour cell killingInternational Journal of Cancer, 2007
- Hepatocellular carcinoma: From bedside to proteomicsProteomics, 2001
- CD40 expression on human lung cancer correlates with metastatic spreadCancer Immunology, Immunotherapy, 2000
- Expression of functional CD40 in human hepatocellular carcinomaHepatology, 1999
- The general rules for the clinical and pathological study of primary liver cancerSurgery Today, 1989